[{"Assets_0_Q3_USD":307436000.0,"CommonStockSharesOutstanding_0_Q3_shares":36917000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":3822000.0,"NetIncomeLoss_1_Q3_USD":-13506000.0,"NetIncomeLoss_3_Q3_USD":-21157000.0,"StockholdersEquity_0_Q3_USD":190116000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20191106"}]